 SAN DIEGO, Nov. 06, 2020 GLOBE NEWSWIRE -- Obalon Therapeutics, Inc. NASDAQ:OBLN, a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its financial results for the third quarter ended September 30, 2020. 